Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-18 1:46 pm Purchase |
2024-10-18 | 13G | Quince Therapeutics, Inc. QNCX |
Genextra S.p.A. | 2,806,611 6.490% |
280,661 (+11.11%) |
Filing History |
| 2023-12-14 5:51 pm Purchase |
2023-10-20 | 13G | Quince Therapeutics, Inc. QNCX |
Genextra S.p.A. | 2,525,950 5.890% |
2,525,950 (New Position) |
Filing History |
| 2022-09-02 4:58 pm Sale |
2022-09-02 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Genextra S.p.A. | 4,000,000 13.400% |
-31,994 (-0.79%) |
Filing History |
| 2020-08-31 4:30 pm Sale |
2020-08-17 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Genextra S.p.A. | 4,031,994 12.200% |
-1,500,000 (-27.11%) |
Filing History |
| 2020-05-15 5:24 pm Sale |
2020-05-13 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Genextra S.p.A. | 5,531,994 16.800% |
-591,834 (-9.66%) |
Filing History |